International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
← All news
Deployments and partnerships

UHN evaluation: 89% of Rho-flagged patients referred for DXA had low bone density

Toronto. Over eight months at the University Health Network, Rho analyzed routine X-rays from more than 10,000 patients and flagged more than 7,000. Of 314 flagged patients referred for a bone density scan, 89.2% were confirmed to have low bone density, OBIO and 16 Bit reported.

The figures were released by OBIO, which supported the evaluation through its Life Sciences Critical Technologies and Commercialization Centre of Excellence, with comment from Dr. Rajesh Bhayana, who leads radiology AI at UHN. They have not been published in a peer-reviewed journal, so they are presented here as reported.

The same report put Rho’s cumulative screening in Canada at more than 340,000 patients, with deployments under way in the United States, Australia and Singapore.